bibliographic resource 4281923 [br/4281923]
https://w3id.org/oc/corpus/br/4281923
- is a
-
- title
-
- CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC).
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-